EUVIMEDEUVIMED entdecken
Open Access

The cost-effectiveness of real-time continuous glucose monitoring versus intermittently scanned continuous glucose monitoring in individuals with insulin-treated Type 2 diabetes mellitus in Canada

Michael Willis iD, Andreas Nilsson iD, Hamza Alshannaq iD, Jessica Matuoka iD, Gregory Norman iD

Journal of Comparative Effectiveness Research · 2025

DOI: 10.57264/cer-2025-0125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2025. Verfasst von Michael Willis und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Swedish Institute for Health Economics, Lund, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Blood Glucose Self-Monitoring, Insulin, Hypoglycemic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Continuous glucose monitoring (CGM) supports glycemic control and reduces diabetes complications. CGM systems include intermittently scanned CGM (is-CGM) and real-time CGM (rt-CGM). While rt-CGM may provide better outcomes than is-CGM, it costs more upfront and its cost-effectiveness in Canada has not been established. We assessed the cost-effectiveness of rt-CGM versus is-CGM in people with insulin-treated Type 2 diabetes mellitus (T2DM) from a Canadian healthcare payer perspective. Materials & methods: We used the ECHO-T2DM microsimulation model to estimate incremental lifetime health outcomes and costs of rt-CGM versus is-CGM. Clinical inputs came from an indirect treatment comparison; cost and utility data were drawn from published sources. Sensitivity analyses tested robustness.

Results

Rt-CGM was more effective and less costly than is-CGM, yielding 0.346 additional quality-adjusted life-years and CAD 2237 in savings over 30 years. Benefits stemmed primarily from better glycemic control and fewer complications, reductions in glycemic events, and reduced fear of hypoglycemia. Although rt-CGM incurred CAD 3867 higher acquisition costs, these were more than offset by avoided complications. Deterministic analysis showed dominance in 14 of 18 scenarios, and cost-effectiveness in the remaining four. Uncertainty analysis showed rt-CGM had an ICER below CAD 50,000 in 98% of simulations.

Discussion

Rt-CGM is potentially a cost-saving alternative to is-CGM among people with insulin-treated T2DM in Canada. This finding was strengthened by rigorous sensitivity analysis. Study strengths include use of a validated microsimulation model and adoption of conservative assumptions. Limitations include absence of head-to-head trial evidence and indirect use of time in and out of range.

Conclusion

Rt-CGM is a potentially cost-saving option for managing insulin-treated T2DM in Canada, with implications for clinical practice and reimbursement policy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Blood Glucose Self-MonitoringInsulinHypoglycemic AgentsHumansCost-Benefit AnalysisCanadaQuality-Adjusted Life YearsBlood GlucoseFemaleMiddle AgedMaleContinuous Glucose Monitoring

Stichwörter der Autor:innen

CanadaECHO-T2DMType 2 diabetescontinuous glucose monitoringcost-utility analysiseconomic modelis-GCMrt-CGM

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • The Swedish Institute for Health Economics, Lund, Sweden.
  • Dexcom Inc, San Diego, CA 92121, USA.

ORCID-Profile: Michael Willis, Andreas Nilsson, Hamza Alshannaq, Jessica Matuoka, Gregory Norman

Zitieren

APA

Willis, M., Nilsson, A., Alshannaq, H., Matuoka, J., & Norman, G. (2025). The cost-effectiveness of real-time continuous glucose monitoring versus intermittently scanned continuous glucose monitoring in individuals with insulin-treated Type 2 diabetes mellitus in Canada. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2025-0125

Vancouver

Willis M, Nilsson A, Alshannaq H, Matuoka J, Norman G. The cost-effectiveness of real-time continuous glucose monitoring versus intermittently scanned continuous glucose monitoring in individuals with insulin-treated Type 2 diabetes mellitus in Canada. Journal of Comparative Effectiveness Research. 2025. doi:10.57264/cer-2025-0125

BibTeX
@article{Willis2025,
  author = {Willis, Michael and Nilsson, Andreas and Alshannaq, Hamza and Matuoka, Jessica and Norman, Gregory},
  title = {The cost-effectiveness of real-time continuous glucose monitoring versus intermittently scanned continuous glucose monitoring in individuals with insulin-treated Type 2 diabetes mellitus in Canada},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2025},
  doi = {10.57264/cer-2025-0125}
}
Kostenlos starten →